Abstract
Multiple drug resistant (MDR) and methicillin-resistant Staphylococcus aureus (MRSA) have become increasingly prevalent as a community acquired infection. As a result limited treatment options are available with conventional synthetic antibiotics. Bioprospecting natural products with potent antimicrobial activity show promise for developing new drugs against this pathogen. In this study, we have investigated the antimicrobial activity of a purple violet pigment (PVP) from an Antarctic bacterium, Janthinobacterium sp. Ant5-2 on 15 clinical MDR and MRSA strains. The colorimetric resazurin assay was employed to determine the minimum inhibitory concentration (MIC90) of PVP against MDR and MRSA. The MIC90 ranged between 1.57 µg/mL and 3.13 µg/mL, which are significantly lower than many antimicrobials tested from natural sources against this pathogen. The spectrophotometrically determined growth analysis and total microscopic counts using Live/dead® BacLight™ fluorescent stain exhibited a steady decrease in viability of both MDR and MRSA cultures following treatment with PVP at the MIC levels. In silico predictive molecular docking study revealed that PVP could be a DNA-targeting minor groove binding antimicrobial compound. The continued development of novel antimicrobials derived from natural sources with the combination of a suite of conventional antibiotics could stem the rising pandemic of MDR and MRSA along with other deadly microbial pathogens.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Gould, I. M. J. Hosp. Infect.2005, 61, 277–282.
Archer, G. L. Clin. Infect. Dis.1998, 26, 1179–1181.
Hidayat, L. K.; Hsu, D. I.; Quist, R.; Shriner, K. A.; Wong-Beringer, A. Arch. Intern. Med.2006, 166, 2138–2144.
Chambers, H. F. Emerg. Infect. Dis.2001, 7, 178–182.
David, M. Z.; Daum, R. S. Clin. Microbiol. Rev.2010, 23, 616–687.
Klein, E.; Smith, D. L.; Laxminarayan, R. Emerg. Infect. Dis.2007, 13, 1840–1846.
Critchley, I. A.; Blosser-Middleton, R. S.; Jones, M. E.; Thornsberry, C.; Sahm, D. F.; Karlowsky, J. A. Antimicrob. Agents Chemother.2003, 47, 1689–1693.
Ardic, N.; Ozyurt, M.; Sareyyupoglu, B.; Haznedaroglu, T. Int. J. Antimicrob. Agents2005, 26, 213–218.
Frazee, B. W.; Lynn, J.; Charlebois, E. D.; Lambert, L.; Lowery, D.; Perdreau-Remington, F. Ann. Emerg. Med.2005, 45, 311–320.
Kuroda, M. et al. Lancet2001, 357, 1225–1240.
Enright, M. C.; Robinson, D. A.; Randle, G.; Feil, E. J.; Grundmann, H.; Spratt, B. G. Proc. Natl. Acad. Sci. USA2002, 99, 7687–7692.
Clardy, J.; Fischbach, M. A.; Walsh, C. T. Nat. Biotechnol.2006, 24, 1541–1550.
Brady, A.; Loughlin, R.; Gilpin, D.; Kearney, P.; Tunney, M. J. Med. Microbiol.2006, 55, 1375–1380.
Obiang-Obounou, B. W.; Kang, O. H.; Choi, J. G.; Keum, J. H.; Kim, S. B.; Mun, S. H.; Shin, D. W.; Kim, K. W.; Park, C. B.; Kim, Y. G.; Han, S. H.; Kwon, D. Y. J. Toxicol. Sci.2011, 36, 277–283.
Chung, P. Y.; Navaratnam, P.; Chung, L. Y. Ann. Clin. Microbiol. Antimicrob.2011, 10, 25–31.
Yu, Y. Y.; Wang, H.; Zhang, S. W.; Wang, B. E. Chin. Med. J.2010, 123, 1017–1020.
Pesewu, G. A.; Cutler, R. R.; Humber, D. P. J. Ethnopharmacol.2008, 116, 102–111.
Molinski, T. F.; Faulkner, D. J. Tetrahedron Lett.2001, 29, 2137–2138.
Lo Giudice, A.; Bruni, V.; Michaud, L. J. Basic Microbiol.2007, 47, 496–505.
Mojib, N.; Philpott, R.; Huang, J. P.; Niederweis, M.; Bej, A. K. Antonie Van Leeuwenhoek2010, 98, 531–540.
Desnottes, J. F. Trend Biotechnol.1996, 14, 134–140.
Mojib, N.; Nasti, T. H.; Andersen, D. T.; Attigada, V. R.; Hoover, R. B.; Yusuf, N.; Bej, A. K. Int. J. Dermatol.2011, 50, 1223–1233.
Anoopkumar-Dukie, S.; Carey, J. B.; Conere, T.; O’sullivan, E.; van Pelt, F. N.; Allshire, A. Br. J. Radiol.2005, 78, 945–947.
Duarte, M.; Giordani, R. B.; De Carli, G. A.; Zuanazzi, J. A.; Macedo, A. J.; Tasca, T. Exp. Parasitol.2009, 123, 195–198.
Martin, A.; Camacho, M.; Portaels, F.; Palomino, J. C. Antimicrob. Agents Chemother.2003, 47, 3616–3619.
Martin, A.; Morcillo, N.; Lemus, D.; Montoro, E.; Telles, M. A.; Simboli, N.; Pontino, M.; Porras, T.; León, C.; Velasco, M.; Chacon, L.; Barrera, L.; Ritacco, V.; Portaels, F.; Palomino, J. C. Int. J. Tuberc. Lung Dis.2005, 9, 901–906.
Rivoire, N.; Ravololonandriana, P.; Rasolonavalona, T.; Martin, A.; Portaels, F.; Ramarokoto, H.; Rasolofo Razanamparany, V. Int. J. Tuberc. Lung Dis.2007, 11, 683–688.
Sanchez, J. G. B.; Kouzetsov, V. V. Braz. J. Microbiol.2010, 41, 270–277.
Hsieh, P. C.; Siegel, S. A.; Rogers, B.; Davis, D.; Lewis, K. Proc. Natl. Acad. Sci. USA1998, 95, 6602–6606.
Piddock, L. J. V. Clin. Microbiol.2006, 19, 382–402.
Durai, R.; Ng, P. C.; Hoque, H. AORN. J.2010, 91, 599–606.
Dharmaratne, H. R. W.; Wijesinghe, W. M. N. M.; Thevanasem, V. J. Ethnopharmacol.1999, 66, 339–342.
Cutler, R. R.; Wilson, P. Br. J. Biomed. Sci.2005, 61, 71–74.
Martins, D.; Costa, F. T. M.; Brocchi, M.; Duran, N. J. Nanopart. Res.2011, 13, 355–363.
Mustaffa, F.; Indurkar, J.; Ismail, S.; Shah, M.; Mansor, S. M. Molecules2011, 16, 3037–3047.
Vera, N.; Solorzano, E.; Ordonez, R.; Maldonado, L.; Bedascarrasbure, E.; Isla, M. I. Nat. Prod. Commun.2011, 6, 823–827.
Choi, J. G.; Kang, O. H.; Lee, Y. S.; Oh, Y. C.; Chae, H. S.; Obiang-Obounou, B.; Park, S. C.; Shin, D. W.; Hwang, B. Y.; Kwon, D. Y. Eur. Rev. Med. Pharmacol. Sci.2010, 14, 1005–1009.
Sianglum, W.; Srimanote, P.; Wonglumsom, W.; Kittiniyom, K.; Voravuthikunchai, S. P. PLoS One2011, 6, e16628.
Chew, Y. L.; Chan, E. W.; Tan, P. L.; Lim, Y. Y.; Stanslas, J.; Goh, J. K. BMC Complement Altern. Med.2011, 11, 12.
Jeong, S. I.; Kim, S. Y.; Kim, S. J.; Hwang, B. S.; Kwon, T. H.; Yu, K. Y.; Hang, S. H.; Suzuki, K.; Kim, K. J. Molecules2010, 15, 7395–7402.
Mulyaningsih, S.; Youns, M.; El-Readi, M. Z.; Ashour, M. L.; Nibret, E.; Sporer, F.; Herrmann, F.; Reichling, J.; Wink, M. J. Pharm. Pharmacol.2010, 62, 1037–1044.
Hannan, A.; Saleem, S.; Chaudhary, S.; Barkaat, M.; Arshad, M. U. J. Ayub. Med. Coll. Abbottabad.2008, 20, 72–74.
Wang, G.; Hindler, J. F.; Ward, K. W.; Bruckner, D. A. J. Clin. Microbiol.2006, 44, 3883–3886.
Nightingale, C. H.; Ambrose, P. G.; Drusano, G. L.; Murakawa, T. (eds.) Antimicrobial pharmacodynamics in theory and clinical practice (Infectious Disease and Therapy). Informa Heathcare: New York, 2nd ed. 2007; p 239–266.
Cenizal, M. J.; Skiest, D.; Luber, S.; Bedimo, R.; Davis, P.; Fox, P.; Delaney, K.; Hardy, R. D. Antimicrob. Agents Chemother.2007, 51, 2628–2630.
Reeves, D. S.; Holt, H. A.; Phillips, I.; King, A.; Miles, R. S.; Paton, R.; Wise, R.; Andrews, J. M. J. Antimicrob. Chemother.1991, 27, 469–474.
Wilson, A. P.; Cepeda, J. A.; Hayman, S.; Whitehouse, T.; Singer, M.; Bellingan, G. J. Antimicrob. Chemother.2006, 58, 470–473.
Panchal, R. G.; Ulrich, R. L.; Lane, D.; Butler, M. M.; Houseweart, C.; Opperman, T.; Williams, J. D.; Peet, N. P.; Moir, D. T.; Nguyen, T.; Gussio, R.; Bowlin, T.; Bavari, S. Antimicrob. Agents Chemother.2009, 53, 4283–4291.
Butler, M. M.; Williams, J. D.; Peet, N. P.; Moir, D. T.; Panchal, R. G.; Bavari, S.; Shinabarger, D. L.; Bowlin, T. L. Antimicrob. Agents Chemother.2010, 54, 3974–3977.
Palchaudhuri, R.; Hergenrother, P. J. Curr. Opin. Biotechnol.2007, 18, 497–503.
Chaires, J. B. Biopolymers1997, 44, 201–215.
Ricci, C. G.; Netz, P. A. J. Chem. Inf. Model.2009, 49, 1925–2935.
Martineau, F.; Picard, F. J.; Roy, P. H.; Ouellette, M.; Bergeron, M. G. J. Clin. Microbiol.1998, 36, 618–623.
Reischl, U.; Linde, H. J.; Metz, M.; Leppmeier, B.; Lehn, N. J. Clin. Microbiol.2000, 38, 2429–2433.
Shrestha, N. K.; Tuohy, M. J.; Hall, G. S.; Isada, C. M.; Procop, G. W. J. Clin. Microbiol.2002, 40, 2659–2661.
Ausubel, F. M.; Brent, R.; Kingston, R. E.; Moore, D. D.; Smith, J. G.; Sideman, J. G.; Struhl, K. (eds.) Current protocols in molecular biology. John Wiley & Sons, Inc: New York, 1987.
Rettori, D.; Duran, N. World J. Microbiol. Biotechnol.1998, 14, 685–688.
Sarker, S. D.; Nahar, L.; Kumarasamy, Y. Methods2007, 42, 321–324.
Boulos, L.; Prévost, M.; Barbeau, B.; Coallier, J.; Desjardins, R. J. Microbiol. Methods1999, 37, 77–86.
Auty, M. A.; Gardiner, G. E.; McBrearty, S. J.; O’sullivan, E. O.; Mulvihill, D. M.; Collins, J. K.; Fitzgerald, G. F.; Stanton, C.; Ross, R. P. Appl. Environ. Microbiol.2001, 67, 420–425.
Ritchie, D. W.; Venkatraman, V. Bioinformatics2010, 26, 2398–2405.
Leite, T. B.; Gomes, D.; Miteva, M. A.; Chomilier, J.; Villoutreix, B. O.; Tuffery, P. Nucleic Acids Res.2007, 35, W568–572.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Huang, J.P., Mojib, N., Goli, R.R. et al. Antimicrobial activity of PVP from an Antarctic bacterium, Janthinobacterium sp. Ant5-2, on multi-drug and methicillin resistant Staphylococcus aureus. Nat. Prod. Bioprospect. 2, 104–110 (2012). https://doi.org/10.1007/s13659-012-0021-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13659-012-0021-4